Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
4.005
-0.125 (-3.03%)
At close: Feb 21, 2025, 4:00 PM
4.130
+0.125 (3.12%)
After-hours: Feb 21, 2025, 7:48 PM EST
Terns Pharmaceuticals Employees
Terns Pharmaceuticals had 66 employees as of December 31, 2023. The number of employees increased by 20 or 43.48% compared to the previous year.
Employees
66
Change (1Y)
20
Growth (1Y)
43.48%
Revenue / Employee
n/a
Profits / Employee
-$1,334,439
Market Cap
340.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 66 | 20 | 43.48% |
Dec 31, 2022 | 46 | 5 | 12.20% |
Dec 31, 2021 | 41 | 11 | 36.67% |
Dec 31, 2020 | 30 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
TERN News
- 2 days ago - Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors - GlobeNewsWire
- 17 days ago - Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 19 days ago - Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 6 weeks ago - Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Terns's stock soars as analysts cheer leukemia data — and predict more gains - Market Watch
- 2 months ago - Terns Pharma broadens beyond obesity drugs with upbeat data in leukemia trial - Market Watch
- 3 months ago - Top 3 Health Care Stocks You'll Regret Missing In Q4 - Benzinga
- 3 months ago - Terns Pharmaceuticals Appoints Heather Turner, J.D., to Board of Directors - GlobeNewsWire